Trial Profile
Pharmacokinetics of single and multiple dose of Mirabegron, a beta-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy Japanese Male Subjects-Study 1
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Pharmacokinetics
- 11 Dec 2015 New trial record